Aemcolo

Chemical Namerifamycin
Dosage FormTablet (oral; 194 mg)
Drug ClassAntibacterials
SystemDigestive
CompanyRedHill Biopharma, Inc.
Approval Year2018

Indication

  • To treat travelers’ diarrhea caused by noninvasive strains of Escherichia coli in adults
Last updated on 6/9/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Aemcolo (Rifamycin) Prescribing Information2019RedHill Biopharma, Inc. Raleigh, NC